I-O blockbusters from Merck, BMS and more linked to poor COVID-19 outcomes: study CDC director: There are likely about 10 cases of COVID-19 for every diagnosed case Moderna aims for light-speed COVID-19 shot rollout with Catalent fill-finish deal LabCorp launches COVID-19 test to track neutralizing antibodies Not even COVID-19 can cause drug prices to go down: report With dexamethasone's sudden COVID-19 blessing, U.S. steroid supplies plummet GAO: HHS lapsed in testing data collection, supply distribution due to COVID-19 pandemic 4 billion COVID-19 vaccine doses? It's possible, CEPI official tells Reuters Biopharma roundup: NIH claims rights to Moderna shot; Oxford turns to South Africa for COVID-19 trials VA has spent $39M to support telehealth amid COVID-19. Veterans say there's still a digital divide. Featured Story | Thursday, June 25, 2020 Cancer patients at Memorial Sloan Kettering who developed COVID-19 faced a higher risk of poor outcomes if they had been treated with checkpoint inhibitors such as Merck's Keytruda, according to a new study. read more |
| |
|---|
|
Top Stories Thursday, June 25, 2020 For every documented case of COVID-19 in the U.S., there are likely 10 more people who have been infected, the head of the Centers for Disease Control and Prevention said Thursday. read more Thursday, June 25, 2020 With the search for a COVID-19 vaccine in hyperdrive, drugmakers have signed a wave of massive manufacturing tie-ups to secure capacity for a possible winner. Now, Moderna has tapped CDMO Catalent to help out on the finishing stages of its shot with the goal of churning out millions of doses within months. read more Thursday, June 25, 2020 LabCorp is launching a new test for COVID-19 antibodies, specifically targeting those used by the immune system to inhibit the novel coronavirus. read more Thursday, June 25, 2020 Not even the coronavirus pandemic is leading to lower drug prices, according to a new analysis. read more Thursday, June 25, 2020 Demand for up-and-coming COVID-19 treatment dexamethasone is intensifying, supplies are running short and drugmakers may not be able to keep up, industry experts say. That's especially true for the injectable form of the drug, which has been on the FDA shortage list for months. But some suppliers are stepping up to help fill the void. read more Thursday, June 25, 2020 A federal watchdog detailed major lapses in HHS' response to the COVID-19 pandemic, including issues with CDC testing data collection and supply allocation. read more Thursday, June 25, 2020 As dozens of COVID-19 vaccines race ahead at record speeds, industry watchers have raised concerns over the resources needed for a massive immunization push. Behind the scenes, the Coalition for Epidemic Preparedness Innovations is laying the groundwork for the production and distribution of billions of doses, an official told Reuters. read more Thursday, June 25, 2020 The NIH reportedly owns a stake in Moderna's COVID shot, increasing the odds that it could be made widely available. Oxford University launched trials of its COVID vaccine in South Africa. Plus, LabCorp aims to supply a new antibody test to blood banks and biopharmas. And a government watchdog blasted the CDC for shoddy testing. read more Thursday, June 25, 2020 The VA has seen telehealth visits surge 1,000% during the COVID-19 pandemic and has spent $39 million supporting virtual care. A department official told Congress that the department plans to expand virtual care for veterans even after the health crisis subsidies. read more |
